NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002013

Registered date:29/05/2009

Biomarker-Cohort Study of Adjuvant Chemotherapy for Stage III Colon Cancer

Basic Information

Recruitment status Complete: follow-up continuing
Health condition(s) or Problem(s) studiedColon cancer
Date of first enrollment2009/04/01
Target sample size3000
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeRelationship between expression levels of the enzymes and DFS, RFS, OS and adverse effects.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria1) Colon cancer (adenocarcinoma) 2) Curatively resected (R0) 3) Pathologically confirmed stage III 4) No preoperative chemotherapy or adjuvant radiotherapy 5) With FU-based adjuvant chemotherapy 6) Written informed consents
Exclude criteria1) Synchronous or metachronous multiple cancers 2) Contraindication of FU drugs 3) The investigator considers not suitable for the study

Related Information

Contact

public contact
Name Kenichi Sugihara, M.D., PhD
Address 1-5-45, Yushima , Bunkyo-ku, Tokyo, 113-8519, Japan Japan
Telephone 03-5803-5261
E-mail k-sugi.srg2@tmd.ac.jp
Affiliation Tokyo Medical and Dental University, Graduate School Dept. of Surgical Oncology
scientific contact
Name Kenichi Sugihara, M.D., PhD
Address 1-5-45, Yushima , Bunkyo-ku, Tokyo, 113-8519, Japan Japan
Telephone 03-5803-5261
E-mail
Affiliation Tokyo Medical and Dental University, Graduate School Dept. of Surgical Oncology